Lycia Therapeutics Inc. (LYCA) forecast
Lycia Therapeutics Inc. (LYCA) forecast: price $35.16, trailing P/E n/a, forward P/E n/a. How to read the street's path.
The live LYCA price is $35.16. Trailing P/E is n/a and forward P/E is n/a. The forecast that matters is the earnings path those ratios imply, not a single target price.
A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.
Use this page for the LYCA forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.
Learn: Forward P/E · Analyst forecast · DCF
Full LYCA quote · Dividends · Price prediction · Academy
Questions
What is LYCA's forward P/E?
The latest forward P/E on Stocklytics is n/a, against a trailing P/E of n/a and a price of $35.16.
Is the analyst target the forecast?
It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.